3921 Na(+)-translocating NADH-quinone reductase subunit D
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Lipids and lipid-like molecules | 5 | 0.9 | 5.69× | not tested | |
| Nucleosides, nucleotides, and analogues | 4 | 2.2 | 1.83× | not tested | |
| Organic acids and derivatives | 2 | 1.2 | 1.64× | not tested | |
| Homogeneous metal compounds | 3 | 3.9 | 0.78× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03247 | FMN | Flavin mononucleotide | 12 |
| DB00123 | LYS | Lysine | 2 |
| DB04327 | PEE | Phosphatidylethanolamine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FES | FE2/S2 (INORGANIC) CLUSTER | 76 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 12 |
| FMN | FLAVIN MONONUCLEOTIDE | 10 |
| NAmetal | SODIUM ION | 6 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 6 |
| CAmetal | CALCIUM ION | 2 |
| FEmetal | FE (III) ION | 2 |
| LYS | LYSINE | 2 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 2 |